Biogen, Inc. filled the longest-term opening on its executive team, announcing on 6 September that the company has hired Jane Grogan as executive vice president and head of research, a position that opened up when long-time Biogen executive Alfred Sandrock retired from his role as head of R&D in 2021. But while Sandrock kept the firm’s research and development largely focused on neurology, Grogran’s recruitment may be the biggest signal yet that Biogen is considering more of a pivot toward immunology.
Grogan will fill a position held on an interim basis for more than a year by current EVP and head...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
